New research reveals the immune system’s cancer-killing T cells are more effective in a tumour’s oxygen-starved environment when they have access to growth factor VEGF-A.
Killer immune cells hunting and destroying cancer cells and biological scissors that cut out defective genes are just some of technologies that Cambridge researchers are developing.